• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Velano Vascular wins FDA 510(k) for Pivo needle-free blood draw device

Velano Vascular wins FDA 510(k) for Pivo needle-free blood draw device

February 27, 2017 By Fink Densford

Velano VascularVelano Vascular said today it won FDA 510(k) clearance for its Pivo needle-free vascular access device designed for drawing blood.

The San Francisco, Calif.-based company said its Pivo is a single-use disposable device designed to take blood samples from indwelling peripheral IV lines to reduce the amount of needle sticks and central line acces for blood collection.

“Our experience with Pivo illuminates that blood draws can be a painless, lower risk experience for patients and practitioners. By further improving the usability and accessibility of this innovation, the potential exists for a global standard of more compassionate care,” Sutter Health chief nurse officer Anna Kiger said in a prepared statement.

Velano Vascular said its Pivo is currently in use at multiple health systems across the US with broader availability planned for later this year.

“The deliberate and thoughtful design inputs for the next generation of Pivo reflect our commitment to rapid product development cycles informed by real world experience in the country’s leading health systems. Feedback from hundreds of practitioners already using our technology reinforced Pivo’s ability to enhance the blood draw experience for patients and clinical staff, and helped us to develop a next generation product better suited for widespread adoption,” CEO Eric Stone said in a press release.

Last February, Velano Vascular said it raised another $3.5 million for its Pivo needle-free blood draw device. The company said it planned to use the proceeds from the round to further develop and commercialize the device.

Prior backers First Round Capital, White Owl Capital, Kapor Capital, Safeguard Scientifics, Griffin Hospital, The Children’s Hospital of Philadelphia and “a number of health industry veterans” joined the round, the company said. New investors included ex-Becton Dickinson (NYSE:BDX) chairman & CEO Ed Ludwig, “individual members of the Medline leadership team,” Oscar S. Schafer, Qosina founder Stuart Herskovitz and D-W Investments, Velano said.

Filed Under: 510(k), Blood Management, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Velano Vascular

More recent news

  • BD files patent infringement lawsuit against Baxter over infusion pump tech
  • Tandem Diabetes Care subsidiary earns new FDA clearance for insulin infusion set
  • Apreo Health emerges from stealth with positive data for lung scaffold
  • Tivic adds new vagus nerve stim patent
  • Study backs Teleflex stapler for reducing post-op GERD rates

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy